Exchange: NYSE·Updated 07:58 PM EST

POM News

News
all
press releases
POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions
POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare SolutionsPR NewswireGUANGZHOU, China, Nov. 11, 2026 Company emphasizes the expanding...
PR Newswire
POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions
POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare Solutions POMDOCTOR LIMITED Highlights Real-World Data as a Strategic Foundation for AI-Enabled Healthcare SolutionsPR NewswireGUANGZHOU, China, Nov. 11, 2026 Company emphasizes the expanding...
PR Newswire
More News
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price RequirementPR NewswireGUANGZHOU, China, Nov. 6, 2026 GUANGZHOU, China, Nov. 6, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a...
PR Newswire
POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare Payment POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare PaymentPR NewswireGUANGZHOU, China, Nov. 4, 2026 Building a Four-Tier Revenue Structure...
PR Newswire
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing RequirementsPR NewswireGUANGZHOU, China, Nov. 2, 2026 GUANGZHOU, China, Nov. 2, 2026 /PRNewswire/ -- POMDOCTOR...
PR Newswire
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 14.6% to $3.3 during Tuesday's pre-market session. The company's market cap stands at $14.4 million. Pomdoctor (NASDAQ:POM) stock movedread more...
Benzinga
Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares rose 8.72% toread more...
Benzinga
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on NasdaqPR NewswireGUANGZHOU, China, Oct. 19, 2026 GUANGZHOU, China, Oct. 19, 2026...
PR Newswire
The company has been targeted in an aggressive two-year-old campaign to delist suspicious Chinese companies from Wall Street image credit: Bamboo Works Key Takeaways: Here today, gone tomorrow. Thatread more...
Benzinga
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive HealthcarePR NewswireGUANGZHOU, China, Oct. 12, 2026GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or...
PR Newswire
Goodyear names Joe Hinrichs chair, Pomdoctor faces Nasdaq delisting; Cryo-Cell earnings rise; SMP and Quantum announce CFO changes.read more...
Benzinga

Advertisement|Remove ads.